MTCR

Metacrine (MTCR)

Metacrine Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:MTCR

<< 前へ 1 2 3 4 5 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2022/03/04	06 : 07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MTCR	Metacrine Inc
2022/03/02	08 : 00	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MTCR	Metacrine Inc
2022/03/02	07 : 46	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MTCR	Metacrine Inc
2022/02/25	06 : 22	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MTCR	Metacrine Inc
2022/02/25	06 : 05	GlobeNewswire Inc.	Metacrine Announces Executive Leadership Changes	NASDAQ:MTCR	Metacrine Inc
2022/02/12	06 : 53	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:MTCR	Metacrine Inc
2022/02/11	23 : 49	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MTCR	Metacrine Inc
2022/02/11	22 : 05	GlobeNewswire Inc.	Metacrine Updates IBD Clinical Development Strategy and Implements Restructuring Plan	NASDAQ:MTCR	Metacrine Inc
2022/02/11	06 : 07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MTCR	Metacrine Inc
2022/01/29	07 : 07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MTCR	Metacrine Inc
2022/01/19	10 : 51	TipRanks	RBC Capital Sticks to Its Hold Rating for Metacrine (MTCR)	NASDAQ:MTCR	Metacrine Inc
2021/12/28	06 : 46	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MTCR	Metacrine Inc
2021/12/28	06 : 41	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MTCR	Metacrine Inc
2021/12/28	06 : 41	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MTCR	Metacrine Inc
2021/12/28	00 : 35	TipRanks	Metacrine (MTCR) Receives a Hold from H.C. Wainwright	NASDAQ:MTCR	Metacrine Inc
2021/12/27	22 : 06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MTCR	Metacrine Inc
2021/12/27	22 : 00	GlobeNewswire Inc.	Metacrine Announces Resignation of Chief Medical Officer	NASDAQ:MTCR	Metacrine Inc
2021/11/12	22 : 12	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:MTCR	Metacrine Inc
2021/11/12	22 : 07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MTCR	Metacrine Inc
2021/11/11	22 : 00	GlobeNewswire Inc.	Metacrine Reports Third-Quarter 2021 Results	NASDAQ:MTCR	Metacrine Inc
2021/11/02	21 : 07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MTCR	Metacrine Inc
2021/11/02	21 : 00	GlobeNewswire Inc.	Metacrine Reports Topline Results for MET409 Phase 2a Combination Trial In Patients with Type 2 Diabetes and NASH	NASDAQ:MTCR	Metacrine Inc
2021/10/22	05 : 08	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MTCR	Metacrine Inc
2021/10/22	05 : 01	GlobeNewswire Inc.	Metacrine Reports Interim Results for MET642 Phase 2a Trial in Patients with NASH and Announces a Strategic Re-Prioritization of Its Clinical Development Programs	NASDAQ:MTCR	Metacrine Inc
2021/10/05	06 : 02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MTCR	Metacrine Inc
2021/09/16	05 : 40	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MTCR	Metacrine Inc
2021/09/09	21 : 05	GlobeNewswire Inc.	Metacrine Achieves Full Enrollment for MET642 Phase 2a Trial in Patients With Nash	NASDAQ:MTCR	Metacrine Inc
2021/09/08	21 : 05	GlobeNewswire Inc.	Metacrine to Host Virtual R&D Day for Analysts and Investors on September 15, 2021	NASDAQ:MTCR	Metacrine Inc
2021/09/07	21 : 05	GlobeNewswire Inc.	Metacrine to Present at H.C. Wainwright 23rd Annual Global Investment Conference	NASDAQ:MTCR	Metacrine Inc
2021/08/12	23 : 35	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:MTCR	Metacrine Inc